Authors:
Barrett, JS
Gibiansky, E
Hull, RD
Planes, A
Pentikis, H
Hainer, JW
Hua, TA
Gastonguay, M
Citation: Js. Barrett et al., Population pharmacodynamics in patients receiving tinzaparin for the prevention and treatment of deep vein thrombosis, INT J CL PH, 39(10), 2001, pp. 431-446
Citation: Rd. Hull et al., Low-molecular-weight heparin prophylaxis: Preoperative versus postoperative initiation in patients undergoing elective hip surgery, THROMB RES, 101(1), 2001, pp. V155-V162
Authors:
Hull, RD
Fluder, EM
Singh, SB
Nachbar, RB
Kearsley, SK
Sheridan, RP
Citation: Rd. Hull et al., Chemical similarity searches using latent semantic structural indexing (LaSSI) and comparison to TOPOSIM, J MED CHEM, 44(8), 2001, pp. 1185-1191
Authors:
Singh, SB
Sheridan, RP
Fluder, EM
Hull, RD
Citation: Sb. Singh et al., Mining the chemical quarry with joint chemical probes: An application of latent semantic structure indexing (LaSSI) and TOPOSIM (dice) to chemical database mining, J MED CHEM, 44(10), 2001, pp. 1564-1575
Authors:
Hull, RD
Pineo, GF
Stein, PD
Mah, AF
MacIsaac, SM
Dahl, OE
Ghali, WA
Butcher, MS
Brant, RF
Bergqvist, D
Hamulyak, K
Francis, CW
Marder, VJ
Raskob, GE
Citation: Rd. Hull et al., Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty - A systematic review, ARCH IN MED, 161(16), 2001, pp. 1952
Authors:
Hull, RD
Pineo, GF
Stein, PD
Mah, AF
MacIsaac, SM
Dahl, OE
Butcher, M
Brant, RF
Ghali, WA
Bergqvist, D
Raskob, GE
Citation: Rd. Hull et al., Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: A systematic review, ANN INT MED, 135(10), 2001, pp. 858-869
Authors:
Dahl, OE
Bergqvist, D
Cohen, AT
Frostick, SP
Hull, RD
Citation: Oe. Dahl et al., Low-molecular-weight heparin as prophylaxis against thromboembolism after total hip replacement - The never-ending story?, ACT ORTH SC, 72(2), 2001, pp. 199-201
Citation: Rd. Hull, New insights into extended prophylaxis after orthopaedic surgery - the North American Fragmin Trial Experience, HAEMOSTASIS, 30, 2000, pp. 95-100
Authors:
Hull, RD
Raskob, GE
Brant, RF
Pineo, GF
Elliott, G
Stein, PD
Gottschalk, A
Valentine, KA
Mah, AF
Citation: Rd. Hull et al., Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism, ARCH IN MED, 160(2), 2000, pp. 229-236
Authors:
Hull, RD
Pineo, GF
Francis, C
Bergqvist, D
Fellenius, C
Soderberg, K
Holmqvist, A
Mant, M
Dear, R
Baylis, B
Mah, A
Brant, R
Citation: Rd. Hull et al., Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients - A double-blind, randomized comparison, ARCH IN MED, 160(14), 2000, pp. 2199-2207
Authors:
Hull, RD
Pineo, GF
Francis, C
Bergqvist, D
Fellenius, C
Soderberg, K
Holmqvist, A
Mant, M
Dear, R
Baylis, B
Mah, A
Brant, R
Citation: Rd. Hull et al., Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients - A double-blind, randomized comparison, ARCH IN MED, 160(14), 2000, pp. 2208-2215
Authors:
Hull, RD
Raskob, GE
Brant, RF
Pineo, GF
Stein, PD
Mah, AF
Citation: Rd. Hull et al., Is there enough evidence that low-molecular-weight heparin is superior to unfractionated heparin in pulmonary embolism? In reply, ARCH IN MED, 160(13), 2000, pp. 2065-2066
Citation: Pd. Stein et al., Withholding treatment in patients with acute pulmonary embolism who have ahigh risk of bleeding and negative serial noninvasive leg tests, AM J MED, 109(4), 2000, pp. 301-306
Citation: Rd. Hull et al., A randomized trial of the effect of low molecular weight heparin vs. warfarin on mortality in the long-term treatment of proximal vein thrombosis, ACUTE PULMONARY EMBOLISM, 2000, pp. 161-174
Authors:
Tapson, VF
Carroll, BA
Davidson, BL
Elliott, CG
Fedullo, PF
Hales, CA
Hull, RD
Hyers, TM
Leeper, KV
Morris, TA
Moser, KM
Raskob, GE
Shure, D
Sostman, HD
Thompson, BT
Citation: Vf. Tapson et al., The diagnostic approach to acute venous thromboembolism - Clinical practice guideline, AM J R CRIT, 160(3), 1999, pp. 1043-1066
Citation: Rd. Hull, The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement - Discussion, J VASC SURG, 30(5), 1999, pp. 820-820
Citation: Gf. Pineo et Rd. Hull, Prophylaxis of venous thromboembolism following orthopedic surgery: Mechanical and pharmacological approaches and the need for extended prophylaxis, THROMB HAEM, 82(2), 1999, pp. 918-924
Citation: Rd. Hull et Gf. Pineo, Extended prophylaxis against venous thromboembolism following total hip and knee replacement, HAEMOSTASIS, 29, 1999, pp. 23-31